NCT04579861: GO SOAR1

GO SOAR1: Post-Operative Morbidity and Mortality Following Gynaecological Oncology Surgery

Status unknown Last updated 9 March 2021

What this trial tests

trial testing Prospective data collection following gynaecological oncology surgery in Gynecologic Cancer in 1,100 participants. Status unknown.

Timeline

19 January 2021

Primary endpoint
31 December 2022

31 December 2023

Quick facts

Lead sponsor	Faiza Gaba
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,100
Start date	19 January 2021
Primary completion	31 December 2022
Estimated completion	31 December 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

• Prospective data collection following gynaecological oncology surgery

Conditions studied

• Gynecologic Cancer — all drugs for Gynecologic Cancer →
• Surgery — all drugs for Surgery →
• Surgery--Complications — all drugs for Surgery--Complications →

Sponsor

Faiza Gaba

Who can join

18 and older, female only, with Gynecologic Cancer or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR) will develop a network of gynaecological oncology surgeons, surgical departments and other interested parties that will have the long-term ability to collaborate on outcome studies. The aims of the Collaborative are to:

1. Set the research agenda through research prioritisation in gynaecological oncology surgical outcomes.
2. Gather high quality data via a centralised database accessible to all sites that perform gynaecological oncology surgery.
3. Build sustainable international research by producing protocols/guidelines.
4. Train the researchers and leaders of tomorrow by providing open access to all GO SOAR training materials.

The Collaborative will lead to several studies.

The first GO SOAR collaborative study (GO SOAR1) will evaluate international variation of post-operative morbidity and mortality following gynaecological oncology surgery between country groups defined by the human development index (HDI).

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

1. International Variations in Surgical Morbidity and Mortality Post Gynaecological Oncology Surgery: A Global Gynaecological Oncology Surgical Outcomes Collaborative Led Study (GO SOAR1).
   Gaba F, Ash K, Blyuss O, Bizzarri N, et al · · 2023 · cited 8× · PMID 37894368 · DOI 10.3390/cancers15205001
2. Predicting Risk of Post-Operative Morbidity and Mortality following Gynaecological Oncology Surgery (PROMEGO): A Global Gynaecological Oncology Surgical Outcomes Collaborative Led Study.
   Gaba F, Mohammadi SM, Krivonosov MI, Blyuss O, et al · · 2024 · cited 5× · PMID 38893143 · DOI 10.3390/cancers16112021
3. Determining post-operative morbidity and mortality following gynecological oncology surgery: protocol for a multicenter, international, prospective cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative-GO SOAR).
   Gaba F, Bizzarri N, Kamfwa P, Saiz A, et al · · 2021 · cited 5× · PMID 34489356 · DOI 10.1136/ijgc-2021-002586